TGFB1 and cancer: 112 out of 130 patients did not show P-Smad2L or P-Smad3L staining in gastric cancer cells, suggesting that the proposed shift in phosphorylation of R-Smad may not contribute to TGF-β mediated carcinogenesis in this type of cancer.